Clinical trial
Alteration of Thrombelastography and Hemostatic Function in Patients Undergoing Total Knee Arthroplasty With Intra-articular Tranexamic Acid Administration
NCT05490160 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alteration of Thrombelastography and Hemostatic Function in Patients Undergoing Total Knee Arthroplasty With Intra-articular Tranexamic Acid Administration
- Lead sponsor
- RenJi Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 5, 2022
- Completion date
- August 28, 2022
- Enrollment
- 54 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
arthropathy of knee